Dermashine Pro Launch at ACE 2026

The Aesthetics Conference & Exhibition (ACE) 2026 in London marked the European launch of Dermashine Pro, a precision skin infusion technology designed to transform how injectable skin treatments are delivered in aesthetic clinics.

During the conference, leading aesthetic doctor Dr Vincent Wong and consultant plastic surgeon Mr Abdulbaky presented their insights on how this new technology could change the way practitioners approach injectable skin therapies.

The presentations took place at the Novus Medical stand, where clinicians and clinic owners had the opportunity to see the system demonstrated live.

A New Approach to Injectable Skin Treatments

Injectable treatments such as skin boosters, polynucleotides and regenerative therapies have become some of the most popular procedures in aesthetic medicine.

However, despite growing demand, the delivery of these treatments has remained largely unchanged for many years. Most injectable skin treatments are still performed manually using syringes, which can be time-consuming and physically demanding for practitioners.

Dermashine Pro introduces a different approach.

Using automated multi-needle delivery combined with controlled depth and vacuum stabilisation, the technology enables practitioners to deliver injectable treatments quickly and consistently.

During the presentations at ACE, Dr Vincent Wong highlighted how innovations in treatment delivery can help improve efficiency within modern aesthetic clinics.

Clinical Insights from Dr Vincent Wong

Dr Vincent Wong is widely recognised for his work in aesthetic medicine and education.

During his presentation, he discussed the increasing demand for regenerative injectable treatments and the importance of developing technologies that help practitioners deliver these treatments efficiently.

He explained that many clinics now offer a wide range of injectable skin therapies, including:

• skin boosters
• polynucleotide treatments
• regenerative injectables
• mesotherapy protocols

While these treatments can produce excellent outcomes, they often require significant practitioner time when delivered manually.

Technologies such as Dermashine Pro aim to improve efficiency by standardising the injection process.

Surgical Perspective from Mr Abdulbaky

Consultant plastic surgeon Mr Abdulbaky also shared his perspective on the evolving role of injectable therapies in aesthetic practice.

As demand for non-surgical treatments continues to grow, many clinics are expanding their treatment portfolios to include regenerative injectable procedures.

Mr Abdulbaky highlighted the importance of technologies that allow practitioners to deliver treatments safely, consistently and efficiently.

Precision infusion technologies such as Dermashine Pro represent an interesting development in this area.

Demonstrating Dermashine Pro at ACE

Throughout the conference, the Novus Medical team demonstrated the Dermashine Pro system to aesthetic doctors, nurses and clinic owners attending ACE.

Clinicians were able to see how the system uses:

• automated multi-needle delivery
• adjustable injection depth
• vacuum stabilisation

to standardise injectable treatments.

One of the most notable advantages discussed during the demonstrations was treatment efficiency.

While traditional injectable treatments may take 30 to 45 minutes, precision infusion technology can deliver a full-face treatment in approximately 5 to 6 minutes.

The Future of Precision Skin Infusion

The launch of Dermashine Pro at ACE reflects the continuing evolution of aesthetic medicine.

As clinics offer an increasing range of injectable treatments, technologies that help standardise delivery and improve efficiency may play an important role in the future of aesthetic practice.

With strong interest from clinicians at the conference, Dermashine Pro is now being introduced to aesthetic clinics across the UK.

Learn More About Dermashine Pro

Clinics interested in exploring precision skin infusion technology can arrange a demonstration with the Novus Medical team.

To learn more about Dermashine Pro and how it may support your clinic, contact Novus Medical for further information.